Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan:6:e2100400.
doi: 10.1200/PO.21.00400.

Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion

Affiliations
Case Reports

Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion

Marina Gaule et al. JCO Precis Oncol. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Valeria MerzConsulting or Advisory Role: Amgen Davide MelisiConsulting or Advisory Role: Baxter, Lilly, Evotec, Incyte, iOncturaResearch Funding: Shire, Celgene, Incyte, iOnctura, RocheNo other potential conflicts of interest were reported.

Figures

FIG 1.
FIG 1.
Histologic features of the tumor. (A) Micrograph of the lesion, consisting of large nodules of tumor cells. (B) Micrograph of the tumor at higher magnification, showing tumor cells disposed in acinar structures and characterized by rounded nuclei with finely dispersed chromatin and conspicuous nucleoli. (C) Negative immunohistochemical reaction for chromogranin A with some scattered non–neoplastic-positive cells. (D) Negative immunohistochemical stain for synaptophysin with a remaining cluster of non–neoplastic-positive cells.
FIG 2.
FIG 2.
(A) Fluorescence in situ hybridization analysis using a break-apart probe. A fusion of the red and green signals corresponds to the intact chromosome, and the split signals are indicative of the ALK rearrangement. (B) Immunohistochemistry for ALK by using 5A4 antibody. Tumor cells show cytoplasmic expression of the protein (40×) while the rest of cells are completely negative (10×). ALK, anaplastic lymphoma kinase.
FIG 3.
FIG 3.
CT scan showing (A) supraclavicular left lymph node, (D) liver, and (G) abdominal lymph nodes before and during treatment with alectinib after the detection of a novel KANK4-ALK genes fusion. After (B, E, and H) 2 and (C, F, and I) 4 months of alectinib, CT scan detected decreasing of target metastasis. Colored lines indicate lesions' major diameters. CT, computed tomography.

Similar articles

Cited by

References

    1. Al-Hader A, Al-Rohil RN, Han H, et al. : Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors. World J Gastroenterol 23:7945-7951, 2017 - PMC - PubMed
    1. Melisi D, Calvetti L, Frizziero M, et al. : Pancreatic cancer: Systemic combination therapies for a heterogeneous disease. Curr Pharm Des 20:6660-6669, 2014 - PubMed
    1. Wisnoski NC, Townsend CM Jr, Nealon WH, et al. : 672 patients with acinar cell carcinoma of the pancreas: A population-based comparison to pancreatic adenocarcinoma. Surgery 144:141-148, 2008 - PubMed
    1. Holen KD, Klimstra DS, Hummer A, et al. : Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol 20:4673-4678, 2002 - PubMed
    1. Jiao Y, Yonescu R, Offerhaus GJ, et al. : Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol 232:428-435, 2014 - PMC - PubMed

Publication types